Aspen’s presence in the Americas is dominated by the businesses in Latin America. Mexico and Brazil are the largest contributors to regional performance. Aspen provides a range of trusted brands across prescription, hospital and over-the-counter (“OTC”) medicines and operates one finished dose form manufacturing facility in Brazil.
|Milk of Magnesia||OTC|
|Ovestin||Estrogen hormone replacement|
NUMBER OF PERMANENT EMPLOYEES
Number of products launched:
Number of product recalls:
Average staff turnover:
Number of work-related fatalities:
|Regional Brands||2 613||2 399||9|
|Sterile Focus Brands||1 393||1 283||9|
|Total||4 006||3 682||9|
Note: Commercial Pharmaceuticals revenue by customer geography.
- The Mexican pharmaceutical market grew 14,0% to USD10,8 billion MAT* June 2021, positively impacted by double-digit growth across the generic and ethical markets.
- Pharmaceutical sales across the total Spanish Latin America market grew 20% to USD21,3 billion MAT June 2021.
Source: IQVIA – June 2021
*MAT = Moving annual total